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Abstract
Reverse Total Shoulder Arthroplasty (RTSA) is a popular treatment for patients with 
rotator cuff damage, glenohumeral arthritis, complex fractures, and previously failed 
total shoulder arthroplasty given its ability to alleviate pain and increase range of motion 
and function. Although RTSA significantly improves functionality, pain, and satisfaction, 
patients need to be given realistic expectations for when to expect improvements, peak 
performance, and plateaus as well as potential risks for negative outcomes. As with any 
surgical procedure, patients are at risk for intraoperative, perioperative, short-term, and 
long-term complications. Thus, the purpose of this review is to discuss the short-term 
and long-term complications, metrics, and length of follow-up for patients who have 
undergone RTSA. In addition, we provide recommendations for a cut-off point between 
short-term and long-term outcomes for RTSA.
Keywords: reverse total shoulder arthroplasty, joint prosthesis, shoulder joint surgery, 
rotator cuff surgery, short-term outcomes, long-term outcomes
1. Introduction
In 1985, Dr. Paul Grammont introduced a new system for reverse total shoulder prosthe-
sis that revolutionized the field by focusing on four key features: (1) the prosthesis must be 
inherently stable; (2) the lever arm of the deltoid must be effective from the initiation of the 
movement; (3) the glenosphere must be large and the humeral cup small to create a semi-
constrained articulation; (4) the center of rotation must be fixed, medialized and distalized 
with respect to the glenoid surface [1, 2]. To this day, Grammont’s core features are still the 
mainstay. Of course, modern prosthetics have been modified since 1985 to avoid scapular 
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notching and impingement between the greater tuberosity and the coracoacromial arch and 
to maximize compressive forces while minimizing shear forces [2, 3].
These advancements contributed directly to the increased utilization of Reverse Total Shoulder 
Arthroplasty (RTSA) [4]. In fact, in the last ten years, the number of RTSAs nearly tripled in 
the United States [5]. Reverse Total Shoulder Arthroplasty (RTSA) is a popular treatment 
for patients with rotator cuff damage, glenohumeral arthritis, complex fractures, and previ-
ously failed total shoulder arthroplasty given its ability to alleviate pain and increase range of 
motion and function. Although RTSA significantly improves functionality, pain, and satisfac-
tion, patients need to be given realistic expectations for when to expect improvements, peak 
performance, and plateaus as well as potential risks for negative outcomes. As with any surgi-
cal procedure, patients are at risk for intraoperative, perioperative, short-term, and long-term 
complications. Thus, the purpose of this review is to discuss the short-term and long-term 
complications, metrics, and length of follow-up for patients who have undergone RTSA. In 
addition, we provide recommendations for a cut-off point between short-term and long-term 
outcomes for RTSA.
Ease range of motion and function in patients with glenohumeral joint disease, displaced 
proximal humeral fractures, rotator cuff tear arthropathy, severe irreparable rotator cuff tears, 
rheumatoid arthritis, and failed shoulder arthroplasty [1–3, 6–8].
2. Surgical approach
The surgical technique for RTSA can be accomplished via two approaches: deltopectorally 
or superolaterally [3, 9]. The deltopectoral approach is the most common and requires an 
experienced surgeon [10]. This surgical technique begins with an incision overlying the del-
topectoral interval, preserving the cephalic vein, then tenotomizing the biceps tendon and 
the subscapularis if still intact [3, 11, 12]. Next, the joint capsule is circumferentially released 
and humeral head exposed to perform a humeral head osteotomy. The humeral head is then 
reamed and broached. Subsequently, the glenoid is exposed, the labrum excised, and the 
glenoid prepared. The guidewire for the glenoid reamer is placed inferiorly so that the gle-
noid baseplate will be flush with the inferior border of the native glenoid rim. This will help 
decrease the risk of scapular notching. By adding an inferior tilt to the position of the base-
plate, the risk of scapular notching can be decreased, which in turn, improves compressive 
forces and helps avoid shear forces on the glenoid component. The baseplate is impacted in 
place, and secured with screws to securely fix the baseplate to the patient’s native glenoid. 
The selected glenosphere is then secured to the baseplate with a Morse Taper fixation mecha-
nism. The selection of the appropriately sized glenosphere is multifactorial. It is based on 
the patient’s size (i.e., 42 mm for larger patients, 39 mm for average size patients, 36 mm for 
smaller patients) and individual patient pathologies. Glenosphere components are available 
in central, lateral offset, and inferior offset designs.
Next, the humeral stem is prepared by sounding the inner diameter of the humeral shaft 
and broaching it to the appropriate size. The final implant is tested with the spacer trials in 
Advances in Shoulder Surgery86
order to gain proper stability and range of motion. Then the real implants are seated and the 
shoulder is reduced. Lastly, the subscapularis is reattached and the biceps are tenodesed with 
heavy nonabsorbable sutures that are placed through drill holes in the humeral metaphysis 
prior to seating of the final implant. However, recent research acknowledges the controversy 
surrounding the reattachment of the subscapularis due to the potential for increasing the 
likelihood of dislocation [13]. The deltopectoral-interval is re-approximated and the incision 
closed. The patient is placed in a shoulder abduction sling for a period of immobilization 
lasting two to 6 weeks with a home physical therapy program [14]. As with all orthopedic 
procedures, the rehabilitation protocol is patient specific and additional rehabilitation may be 
deemed necessary if the patient needs to strengthen external rotation [14].
3. Outcome timeline
What constitutes a short-term versus a long-term outcome? One of the objectives of this 
review is to address the lack of clarity in the literature regarding the timeline of short-
term and long-term outcomes [15]. Bacle and colleagues [15] identified that the majority of 
mechanical loosening reports occurred outside of the first 2 years following a reverse total 
shoulder arthroplasty. In contrast, dislocation, infection, and poor seating of the glenoid com-
ponent were reported within the first 2 years postoperatively; a ratio of 3 to 1 for complica-
tions reported before and after the two-year mark [15]. Furthermore, Bacle and colleagues 
[15] defined medium-term follow-up as a mean of 39 months and long-term follow-up as a 
mean of 150 months. Similarly, Otto and colleagues [16] argued that a follow-up of period of 
24 months was a relatively short time frame to adequately capture long-term complications. 
Thus, 2 years may be a respectable partition between short-term and long-term outcomes.
4. Outcome quantification
The language of RTSA outcomes is a complex task given the wide range of outcomes met-
rics. The most common scoring methods include the following: Range of Motion (ROM), 
Constant-Murley Score (CMS), American Surgeons of Elbow and Shoulder score (ASES), 
Visual Analogue Score (VAS), and the Simple Shoulder Test (SST). Other methods include 
but are not limited to the UCLA Shoulder Score and the Shoulder Pain and Disability Index 
(SPADI) [17–19]. The CMS, first published in 1987, is comprised of four sections: two of which 
are self-reported by the patient—pain and activities of daily living, the remaining two are 
reported by the physician—range of motion and strength [20]. Concerns were raised regard-
ing the score’s ability to account for age and gender; thus, the modified version adjusts for 
both [17]. The ASES was created with the goal of developing a universal outcome measure; it 
too contains patient-reported and physician-reported parts. In addition, the ASES has demon-
strated appropriate validity and reliability in assessing operative and non-operative interven-
tions for shoulder pathology [17]. However, it’s appraisal of functionality may be somewhat 
limited among the older adult population; for example, the questions about “do usual sport” 
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and “throw ball overhand” may not be relevant [19]. Patient-reported pain is an outcome that 
necessitates acknowledgement, which may be quantified by utilizing the VAS [21]. The VAS 
uses a line measuring 100 mm with pain extremes indicated on either end; no pain and worst 
pain [21]. The patient marks along the continuum where he/she believes their pain is best 
described; the score is then represented by a distance in millimeters [22]. Finally, the SST, is 
used to evaluate patient-reported functionality associated with various shoulder pathology, 
including rotator cuff arthropathy, osteoarthritis, rheumatoid arthritis, and adhesive capsuli-
tis [17, 18]. This questionnaire consists of 12 questions that ask the patient whether he/she may 
perform the given activity [18].
5. Short-term outcomes
Table 1 reviews the outcome measures and length of follow-up from numerous surgical 
studies. Based on these findings, short-term outcomes for RTSA occur postoperatively 
within the first 24 months. It also addresses the variation in components and metrics used 
in each study.
RTSA significantly improves functionality, pain, and satisfaction; but when are patients 
expected to experience peak performance with a new prosthesis? Is there a point in time 
when a patient should expect a plateau in their improvements over time? In 2015, Simovitch 
and colleagues [23] demonstrated that at the 6-month follow-up, less than 5% of patients 
reported decreases in SST, UCLA Shoulder Score, CMS, ASES, SPADI. More importantly, 
“full improvement” was achieved in the 12–24 month range [23]. Thus, they concluded that 
the majority of improvement occurred within the first 6 months, as evidenced by the scores for 
each of the five measures [23]. These findings stress the importance of patient selection, expec-
tations for RTSA, expertise in intraoperative optimization, and strict postoperative physical 
therapy management. The concept of rapid improvement during the first 6 months with pla-
teau at 12 months was also reported by Muller and colleagues in 2017 [24], in which flexion, 
abduction, and external rotation in 90 degrees of abduction demonstrated profound increases 
by 42°, 38° and 33° respectively at 6 months. Additional follow-ups at 12, 24, and 60 months 
displayed minimal additional improvement [24]. Supplementary evidence of RTSA success 
was seen by Yoon and colleagues [25] in 2017 with forward flexion increase of 64°, external 
rotation increase of 13° and pain reduction of (−3) at 12 months postoperatively.
Two factors that have been shown to increase CMS and ROM testing during the short-term 
period are deltoid volume [25] and glenosphere size [24] respectively. Preoperative deltoid 
muscle volume was an independent prognostic factor for functional outcomes with CMS 
(p = 0.011), underscoring the importance of patient selection and discussing the potential for 
negative outcomes such as atrophied deltoid muscle [25]. Likewise, Muller and colleagues 
[24] conducted a retrospective analysis in 2017, to demonstrate that patients that had received 
a 44 mm glenosphere had greater external rotation in adduction and abduction strength over 
the 36 mm glenosphere. Moreover, they found no significant differences in functional scores 
or complication rates [24].
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Study Sample 
size
Age Follow up Complications Component 
variability
Risk factors Scoring 
Mechanism
Alentorn-
Geli et al 
(2017)
38 77–83 
years
3–60 
months
Infection
Glenoid 
loosening
Revisions
Component 
Dislocation
Comprehensive 
reverse shoulder 
system (Biomet)
Encore reverse (DJO 
Global)
Delta reverse 
shoulder System
(DePuy)
Tobacco use
Diabetes
Mellitus
Hypertension
Increased age
FF
ER
Anakwenze 
et al (2016)
1147 45–84 
years
3–36 
months
Aseptic revision
Mortality
Surgical site 
infection
Readmission
- Increased 
BMI
Diabetes
Mellitus
Increased age
-
Bacle et al 
(2017)
186 23–86 
years 
(72.7 
mean)
24–150 
months
Dislocation
Scapular 
Notching
Infection
Nerve Palsy
Glenoid 
Loosening
Humeral 
Loosening
Glenoid fracture 
Revisions
164 Delta III 
(DePuy)
27 Aequalis 
(Tournier)
Increased age CMS
ROM
Ek et al. 
(2013)
41 46–64 
years
60–171 
months
Infection
Nerve Palsy
Fracture
Dislocation
Component 
Wear
Glenoid 
loosening
Glenoid component 
36mm, 40mm, or 
42 mm
Delta III (DePuy) 
(lateralized humeral 
polyethylene cup)
Anatomical 
Shoulder System
(Zimmer) (6mm 
medialized humeral 
cup)
Previous 
surgery 
on same 
shoulder
CMS
Validated 
electronic 
dynamometer
Feeley et al 
(2014)
54 53–81 
years
30 months Scapular 
notching
Zimmer Reverse 
Trabecular
Metal System
36mm glenosphere 
3mm lateralized
- VAS
ASES score
ROM
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Study Sample 
size
Age Follow up Complications Component 
variability
Risk factors Scoring 
Mechanism
Friedman 
et al (2017)
591 50–93 
years
24 month 
minimum 
(37 month 
mean)
Component 
instability
Scapular 
notching
Equinoxe rTSA 
(Exactech)
- SST
ASES score
UCLA score
CMS
SPADI
Jonusas 
et al (2017)
27 55–85 
years
45 months Heterotopic 
ossification
Tubercule 
malposition
Arrow shoulder 
system with less 
medialized CoR
- SST
CMS
Mollon et al 
(2016)
476 53–90 
years
22–93 
months
Scapular 
notching
Dislocation
Infection
Component 
Loosening
Humeral fracture
Scapular fracture
Equinoxe rTSA 
(Exactech) 36 mm, 
40mm, or 42mm 
glenosphere 
lateralized 2.3mm
Increased age
Increased 
BMI
ROM
ASES score
CMS
SST
Muller et al 
(2017)
68 68–79 
years
6–60 
months
Glenoid 
migration
Component 
loosening
SMR reverse 
shoulder system
(Lima Switzerland 
SA)
36mm or 40mm 
glenosphere
Increased age CMS SPADI
Otto et al. 
(2017)
67 21–54 
years
24–144 
months
Scapular 
notching
Humeral lucency
Glenoid screw 
lucency
Fracture 
(humeral, 
scapular)
Humeral 
dissociation
Infection
Instability
Revision
Reverse shoulder 
system (DJO 
Surgical)
Prior 
shoulder 
surgery
SST
ASES score
Randelli 
et al (2015)
226 64–72 
years
3.8 years Revision
Infection
Fracture
Delta III - Constant Score
ASES score
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Study Sample 
size
Age Follow up Complications Component 
variability
Risk factors Scoring 
Mechanism
Simovitch 
et al (2015)
912 60–78 
years
2 weeks–
139 
months
- Equinoxe rTSA 
system (Exactech)
- SPADI
ASES score
UCLA score
Constant score
Statz et al 
(2016)
41 53–83 
years
2–7.3 years Scapular 
notching
Revision
Nerve palsy
Heterotopic 
ossification
Encore reverse 
shoulder
Prosthesis (DJO 
Surgical)
Delta III, Delta 
Xtend (DePuy)
Comprehensive 
prosthesis (Biomet)
Aequalis Reversed 
Shoulder (Tournier)
Increased 
BMI
Previous 
shoulder 
surgery
Tobacco use
Diabetes 
mellitus
ROM
ASES score
Wierks et al 
(2007)
20 45–88 
years
3–21 
months
Fracture
Poor screw 
fixation
Nerve palsy
Infection/ 
Abscess
Dislocation
Revision
Heterotopic 
ossification
Scapular 
notching
DePuy reverse 
shoulder prosthesis
Tournier reverse 
shoulder prosthesis
- -
Williams 
et al (2017)
17 45–91 
years
10–67.7 
months
Dislocation
Component 
migration
Biomet reverse 
adapter (Bio-
Modular to 
Comprehensive 
conversion)
- VAS
ASES score
Yoon et al 
(2017)
35 66–84 
years
12–35 
months
Scapular 
notching
A/C joint 
separation
Acromial 
fracture
Aequalis reverse 
arthroplasty system 
(Tournier)
Increase BMI
Diabetes 
mellitus
Hypertension
Decreased
BMD
VAS
ASES score
Constant score
SST
ASES = American shoulder and elbow surgeons; SPADI = shoulder pain and disability index; ROM = range of motion; 
UCLA = University of California Los Angeles score; SST = simple shoulder test; VAS = visual analogue score; FF = forward 
flexion; ER = external rotation; BMD = bone mineral density.
Table 1. Comparison of outcome measures and length of follow-up for patients undergoing reverse total shoulder 
arthroplasty.
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Complications are a critical component of RTSA. Patients need to be counseled on intraopera-
tive, perioperative, and notably, short-term complications. The most common intraoperative 
complications are glenoid or humeral fractures along with poor screw fixation [12]. The conse-
quence of poor screw fixation is its lasting impact and conversion to long-term complications 
such as glenoid screw lucency. Zhou and colleagues [13] discussed the prevention techniques, 
such as hand reaming the humerus and preserving glenoid bone stock by avoiding ream-
ing beyond subchondral bone margin. Postoperative short-term complications dominate the 
outcomes of RTSA and range from scapular notching, infection, dislocation, revision, nerve 
palsy, or even heterotopic ossification.
Scapular notching is by far the most common complication during the first 24 months postop-
erative. Scapular notching has an incidence of 38%, 57%, 55% and 73% in four recent studies 
respectively [12, 15, 24, 25]. These findings oblige additional research to review instrumen-
tation and confirm incidence levels on scapular notching in RTSA. In 2014, Feeley and col-
leagues [12] found that decreasing the neck-shaft angle or a higher inclination angle and 
3 mm lateral offset of the glenosphere prosthesis decreased the rate of scapular notching by 
16%. Furthermore, Zhou and colleagues [13] assert that continued complication management, 
by adding inferior placement of the glenosphere, is “the most important factor in the avoid-
ance of inferior impingement.” The next step is to investigate whether scapular notching 
will evolve, both de novo and from early to late stage scapular notching during short-term 
follow-up. An important question to consider is will the patient be free from scapular notch-
ing for the remainder of the prosthesis? [12] Feeley and colleagues [12] observed that of all 
the patients who did not experience scapular notching during the first 12 months (84% of 
patients), showed no new evidence of scapular notching during follow-ups up to 30 months. 
Conversely, Bacle and colleagues [15] found that after early scapular notching diagnoses were 
made, there was a 39% increase in the rate of notching beyond the 2-year follow-up period. 
Thus, superfluous research is essential to answer this question.
Another common short term complication deals with postoperative stability resulting in shoul-
der dislocations. Wierks [12] and colleagues as well as Bacle [15] and colleagues found 10% 
and 22% of dislocations occurred during the short term period. Of note, Bacle and colleagues 
[15] published that of the 15 dislocations documented in the sample size of 67, no cases were 
reported after the 2 year follow-up period. Zhou and colleagues [26] reviewed the most common 
and serious complications associated with RTSA and concluded that instability was a result of 
“lack of soft tissue tension, mechanical impingement, mismatch of the glenosphere and humeral 
socket size and improper version of the prosthesis”. Therefore, to obtain the best outcome for 
patients, extensive knowledge of the prosthesis is imperative, along with understanding how 
to achieve soft tissue tension using vertical offset of your acromion—greater tuberosity distance 
and lateral offset of the tuberosity-glenoid distance [26]. Conversely, controversy exists within 
the RTSA literature regarding the decision to repair the subscapularis. Friedman and colleagues 
showed that subscapularis repair proclaimed no statistical significance over no repair [27]. In 
the study, 340 patients with RTSA plus repair had 0% dislocation rate, versus 251 patients with 
RTSA without repair showing a 1.2% dislocation rate; stating the claim that RTSA plus subscap-
ularis repair is not indicated due to the absence of increase in overall complication rates [27].
Lastly, infections can have serious ramifications on patient satisfaction as well as the overall 
outcomes of the RTSA, resulting in one or two-stage revisions. A study conducted by Wierks 
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and colleagues [12] in 2009, had a 5% infection rate and a study by Bacle and colleagues [15] in 
2017, had an infection rate of 12%. It is important to emphasize that Bacle and colleagues [15] 
documented 8 infections within the first 24 months as compared to only 2 cases in the 12 year 
follow-up period. In the same study, with regards to revision cases in the short-term period, 
6 out of the 8 revision surgeries were caused by infections [15]. Thus, postoperative infections 
that occur in the first two years are the most common reason for revision surgery. In the review 
conducted by Zhou and colleagues [26] in 2015, they compared primary cases and revision 
cases, to find that revision cases were statistically higher than primary cases with regards 
to infections rates, 5.9% vs. 2.9% respectively. Propionibacterium acnes and Staphylococcus epi-
dermidis were the most commonly cultured organisms. Recommendations to decrease infec-
tions include continuation of preoperative antibiotics within one hour of incision and use of 
antibiotic-impregnated cement for surgeries that employ cement the humeral component [26].
6. Long-term outcomes
The patient’s age at the time of the arthroplasty plays a critical role in the survival of the 
prosthesis; younger patients (i.e., < 55 years of age) are more likely to be active in the work-
force, while older patients are less likely to participate in physically strenuous activities and 
be retired [16]. In younger patients, prosthesis survival can exceed 10 years. For example, 
Bacle and colleagues [15] observed a 93% implant survival rate at 10 years; whereas Ek and 
colleagues [28] observed an implant survival rate of 88% at 5 years and 76% at 10 years post-
operatively, regardless of any complications that may have arisen.
The RTSA has been shown to improve pain, strength, range of motion in abduction, external 
rotation, and forward flexion; in addition to showing improvement in metrics, such as ASES, 
SST, CMS, SPADI, and UCLA Should and UCLA Shoulder Score [16, 23, 24, 29]. Outcomes 
beyond the 24-month mark may be impacted by multiple variables, some of which include, 
prosthesis sizes, involvement of fracture, primary versus revision RTSA, and the lifestyle or 
activity level of the patient. In regards to repair of proximal humeral fractures, RTSA was 
found to provide superior results to a hemiarthroplasty for at least 5 years, respectively [30]. 
Muller and colleagues [24] investigated the size of the glenosphere, 36 mm and 44 mm, on 
functional outcomes following RTSA and found that both groups exhibited the most substan-
tial progress in the first 6–24 months, followed by a plateau. Patients’ progress was monitored 
by measuring flexion, abduction, external rotation at 0° and 90° of abduction, internal rotation 
at 90° of abduction, CMS, SPADI, and strength (kg) in abduction. Interestingly, Anakwenze 
and colleagues [31] found that a higher body mass index (BMI) put a patient at risk for deep 
surgical site infection (SSI) up to 3 years following RTSA. Their study looked at the effects of 
increased BMI on postoperative outcomes following a RTSA and total shoulder arthroplasty 
(TSA). Every 5 kg/m [2] increase in BMI was associated with higher risk of 3-year deep SSI 
[31]. In addition to BMI, tobacco use influences the success of the prosthesis up to 12 years 
after an RTSA [32]. Hatta and colleagues [32] found that current smokers had an increased 
risk for infection, component loosening, and fractures compared to non-smokers. Specifically, 
they found that the percentage of patients with periprosthetic fractures jumped 20% at the 
9 year mark after RTSA [32].
Current Outcomes Following Reverse Total Shoulder Arthroplasty: A Composite
http://dx.doi.org/10.5772/intechopen.72545
93
Although, as previously stated, this study implies 24 months as the short-term interval for 
outcomes following an RTSA, short-term complications have the potential to extend into the 
long-term if not addressed or managed appropriately—eventually affecting the longevity of 
the prosthesis. More commonly, long-term complications include glenoid and/or humeral 
component loosening, polyethylene component wear, and scapular notching. Less common 
long-term complications include deep SSI, dislocation, readmission, and fracture; which 
primarily occur within the first 2 years postoperatively. As mentioned above, glenoid or 
humeral loosening is the most common complication observed 2 years after RTSA, particu-
larly with an increased risk following a previously failed shoulder arthroplasty and excess 
mechanical load related to increased BMI [15, 33]. Further, the incidence of component loos-
ening doubles between the second and fifth year follow-up as reported by Alentorn-Geli and 
colleagues [29]. Particlization of the polyethylene component may be of concern with RTSA 
in younger patients due to necessary durability and lifespan of the implant. Riley and col-
leagues [34] investigated the outcomes following RTSA using a metal-on-metal design and 
concluded that it is not an acceptable alternative to RTSA in young patients; they maintain 
that the polyethylene component is the more suitable option. Ek and colleagues [28] con-
ducted a study evaluating RTSA in patients younger than 65 years of age using two groups: 
revision RTSA and primary RTSA. This study observed an increased incidence of scapular 
notching at less than 12 months follow-up and greater than 10 years follow-up; with 56% 
of patients experiencing some degree of scapular notching overall [28]. Conversely, Mollon 
and colleagues [34] reported that only 10% of patients experienced scapular notching; not-
ing that risk factors for scapular notching included lower body weight, lower BMI, and 
RTSA on the non-dominant upper extremity. It is also worth mentioning the correlation 
between longer-term follow-up and increasing incidence of scapular notching [34]; which 
may be attributed to variation in size and placement of the glenosphere, and center of rota-
tion of the prosthesis.
7. Conclusion
Throughout this literature review, several limitations were encountered that include the fol-
lowing: unspecified “normal” postoperative physical rehabilitation protocols, risk factors per-
tinent to specific complications, and lack of research investigating the long term outcomes for 
RTSA. Additional research is needed to examine the aforementioned limitations to enhance 
future outcomes following RTSA.
Scapular notching, dislocations, and infections lead the forefront of persistent complications 
for RTSA. As evidenced in this literature review, the vast majority of improvement plateaus 
around 6 to 24 months. Thus, patient optimization may be accomplished by implementing 
a short-term course of preoperative physical therapy focused on shoulder girdle strength. 
Further, numerous inconsistencies and contradictions were observed in the literature regard-
ing the impact of BMI on RTSA outcomes. Research requires further confirmatory evidence 
before making any strong conclusions about limiting the use of RTSA in patients with 
increased BMI. On the other hand, tobacco use negatively impacts the outcomes following 
RTSA by nearly doubling the overall complication rate.
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